The Trump administration has been rebounding after first stopping the distribution of HIV drugs that saves lives under Pepfar (an emergency plan for AIDS rescue), a global HIV/AIDS initiative of the US government. However, following the general protest, the administration has overturned the decision and resumed the distribution of drugs.
In the evening of Sunday, the Trump administration issued command commanding organizations and medical providers to receive funds through Pepfar, and immediately stopped distribution of HIV drugs. According to New York TimesOn Monday, patients in some countries left the clinic, managed HIVs, and left them without important treatments relying to prevent progress to AIDS.
Pepfar, a program established between the George W. Bush administration, is believed to have saved an estimated life of 25 million in Africa, south of Sahara. Since its establishment, this initiative has been providing important HIV treatment and prevention services for millions of people, including 500,000 children, to survive by antiretrovirus (ARV) drugs. Without continuous access to these drugs, many of these children will develop the risk of developing AIDS and spreading viruses to others.
Dr. Steve Deaks, a medical professor at San Francisco, said: “As I saw in the 1980s, I can return to the situation where the pandemic is exploding. This really can’t happen.”
The ban on the financing of Pep fur has been a part of a more widespread movement by the Trump administration to restrict foreign aid programs, despite the fact that the funds have already been assigned by Congress. This decision has raised concerns that the actions of the administration could lead to important progress in providing important treatments for those in need and controlling HIV diffusion.
on tuesdayIn response to the pressure of public health experts, advocates, and members of the Diet, the Trump administration has overturned the decision to refrain from HIV drugs. Secretary of State Marco Rubio has announced that it will be abandoned to ensure life treatment so that patients can be used. However, it is unknown whether this exemption will be expanded to precautionary treatments such as PREP (pre -exposure prevention), which helps prevent high -risk personal HIV infection.
Before and after and back and forth of the HIV medication distribution, we ignored discussions on the direction of US foreign aid and the more powerful policy priority. Critics argue that these actions could hurt the US reputation as global leaders in public health, especially in the progress of HIV/AIDS.
The administration’s actions came in a wider frozen federal subsidy and loan of domestic programs, including Medicade. The frozen portal for the refund of Medicade was temporarily closed. This is an important service for low -income earners seeking health care. The portal later revived after public pressure, but freezing has reviewed a program related to gender ideology and diversity, and has raised the administration’s intention to reduce it.
The controversy on Pepfer emphasizes the priority of the public health tension surrounding US foreign aid and the public health issues that affect the alienated community. Pepfar’s successful efforts to reduce HIV infections of millions of people, provide treatment, and improve their health results are considered one of the most successful global health initiatives in the United States. Experts have warned that the potential reversal of these efforts could have a miserable consequences of continuous battle with the global HIV/AIDS pandemic.
Members from both sides of the aisle have expressed concern about administration’s actions. Representative Barbara Lee (D-CA), a defender of global health voice, is dangerous due to the intention of Pepfer’s future, an increase in conservative attacks on foreign aid and the approach of the government’s closure. He warned that he was. She called financing frozen “public health around the world and a direct attack on the lives of millions of people.”
As the Trump administration navigates these controversial policy decisions, public health experts, international organizations, and HIV/AIDS supporters are carefully monitoring the situation. The global community is wondering if the United States is continuing to fight HIV/AIDS or as a global health leader because the future of Pepfar and other important health programs depends on the balance. I will come to think.
Until then, the organizations and medical providers involved in Pepfar will work to reach the most necessary people because the world’s HIV/AIDS trends remain a serious health assignment with a wide range of results. I am. As the discussion continued, the interests of people living with HIV/AIDS have never been so high.
Source: Gayety – gayety.co
